News

Ixico cheers FDA approval for contractor Fujirebio's Alzheimer's test
Ixico said it was contracted by Fujirebio Diagnostics Inc, a Tokyo-based biomarker research company, to assist with the development of a new blood-based test for Alzheimer's disease called Lumipulse.
ABC Action News5d
Doctor discusses first FDA-cleared blood test to help diagnose Alzheimer's
The Lumipulse test has specifically been approved to help diagnose the disease in the clinical setting. Dr. Amanada Smith ...
FDA clears blood test that helps early detection of Alzheimer’s
A simple blood draw has now become a powerful tool in the early fight against Alzheimer’s. The FDA has approved the first ...
Agence France-Presse7d
Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G sTREM2 Assay for Research Use Only
Fujirebio, a member of H.U. Group Holdings Inc., is a global leader in the field of high-quality RUO and in vitro diagnostics (IVD) testing. It has more than 50 years’ accumulated experience in the ...
Mirage News7d
Fujirebio Unveils Lumipulse G STREM2 for Neuro Research
Fujirebio, a member of H.U. Group Holdings Inc., is a global leader in the field of high-quality RUO and in vitro diagnostics (IVD) testing. It has more than 50 years' accumulated experience in the ...
WDIO News12d
Alzheimer’s Association weighs in on FDA approval of blood test to help diagnose
The U.S. Food and Drug Administration cleared the first in vitro diagnostic device that tests blood to aid in diagnosing ...
Physician's Weekly13d
FDA Clearance of Blood Test for Alzheimer’s Inspires Cautious Optimism
Dr. Richard G. Stefanacci explains why the FDA's recent clearance of a diagnostic blood test for Alzheimer's deserves ...
Ophthalmology Advisor15d
FDA Gives Marketing Nod to Blood Test for Diagnosing Alzheimer Disease
The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance by the US Food and Drug Administration.
The Indian Express15d
US FDA approves blood test for Alzheimer’s: What this means for early diagnosis
The test, called Lumipulse, was granted breakthrough device approval and is designed for early detection of amyloid plaques associated with Alzheimer’s disease in patients aged over 55 who exhibit ...
WISH-TV19d
Morning Checkup | Could a new blood test help doctors diagnose Alzheimer’s disease earlier?
Last week, the US Food & Drug Administration approved marketing for a blood test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, developed by the Pennsylvania-based biotechnology company ...
Indiatimes20d
Now THIS simple blood test can reveal the onset of Alzheimer's
Cleared for marketing on Wednesday, the Lumipulse G pTau217/ß-Amyloid 1-42 plasma ratio test identifies amyloid plaques, one of the key hallmarks of Alzheimer’s, in adults aged 55 and older who ...
WHYY20d
Philly Alzheimer’s disease researchers call a new diagnostic blood test promising, but advise caution
Amyloid plaque, a feature of Alzheimer's disease, accumulates outside neurons. A new blood test, Lumipulse, measures two subtypes of tau and amyloid proteins, of which certain levels can predict the ...